At5g55150 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At5g55150 antibody; MCO15.10 antibody; Putative F-box protein At5g55150 antibody
Target Names
At5g55150
Uniprot No.

Q&A

What is AT5G55150 and what is its function in Arabidopsis?

AT5G55150 encodes the AtRGGA (Arabidopsis thaliana RNA-binding glycine-rich protein A) protein, which functions as an RNA-binding protein involved in plant stress response mechanisms. Sequence analysis reveals that AtRGGA contains a Suppressor of Tom1 (Stm1) domain at its N-terminal region, similar to the yeast Stm1 nucleic acid-binding protein, and a Hyaluronan-Binding Protein4_Plasminogen Activator Inhibitor-1 mRNA-Binding Protein1 (HABP4_PAI-RBP1) domain typically found in RNA-binding proteins . This protein plays a significant role in salt stress tolerance pathways and appears to function by binding to specific RNA molecules to regulate their processing, stability, or translation during stress conditions .

How is AtRGGA expression regulated under different stress conditions?

AtRGGA transcript abundance shows dynamic regulation under various stress conditions. Research indicates that AtRGGA expression is reduced by salt stress in the short term but increases over longer periods of exposure to abscisic acid (ABA) and osmotic stress . This biphasic response suggests AtRGGA may play different roles during initial stress perception versus long-term adaptation. Transcriptional regulation of AtRGGA appears to be stress-specific, providing the plant with appropriate molecular responses to different environmental challenges .

What is the expression pattern of AtRGGA in plant tissues?

GUS reporter assays driven by the AtRGGA promoter reveal expression in multiple tissues throughout plant development. AtRGGA is expressed in both seedlings and adult plants across several organs, including:

  • Leaves (with particularly strong expression in stomatal guard cells)

  • Roots

  • Inflorescences

  • Siliques

  • Pollen grains and tubes

  • Funiculi attaching seeds to siliques

This broad expression pattern suggests AtRGGA plays important roles in multiple developmental processes and tissues, not just in stress response.

What strategies are most effective for generating antibodies against AT5G55150/AtRGGA?

For generating effective antibodies against AT5G55150, a recombinant protein expression approach in eukaryotic cells is recommended, especially since plant proteins may have post-translational modifications that affect epitope recognition. When developing antibodies against plant proteins like AtRGGA, researchers should:

  • Express the full-length protein or specific domains (such as the RNA-binding domains) with an appropriate tag (His-tag, as used for AtRGGA in published research)

  • Purify the recombinant protein under native conditions to preserve conformational epitopes

  • Immunize mice or rabbits with the purified protein following a standard immunization protocol

  • Screen hybridoma clones for specificity using both the recombinant protein and plant extracts containing the native protein

For heavily glycosylated proteins, expressing the antigen in eukaryotic cells has proven particularly effective in generating high-specificity monoclonal antibodies, as demonstrated for other complex proteins like CD45 .

How can I validate the specificity of an AT5G55150 antibody?

Validation of antibody specificity is crucial for accurate experimental interpretation. For AT5G55150 antibodies, a comprehensive validation strategy should include:

  • Western blotting analysis:

    • Using wild-type Arabidopsis extracts versus rgga knockout mutant lines

    • Testing with recombinant AtRGGA protein as a positive control

    • Including overexpression lines (e.g., 35S::FLAG-RGGA) to confirm increased signal

  • Immunoprecipitation followed by mass spectrometry:

    • Perform IP with the antibody and identify pulled-down proteins

    • The primary hit should be AtRGGA with high confidence scores

  • Immunohistochemistry:

    • Compare staining patterns with known expression data from promoter-GUS fusion studies

    • Include knockout plants as negative controls

    • Check for expected subcellular localization patterns

  • Cross-reactivity testing:

    • Evaluate potential cross-reactivity with related glycine-rich RNA-binding proteins in Arabidopsis

What epitopes should be targeted for optimal AT5G55150 antibody development?

When designing antibodies against AtRGGA, targeting unique regions will enhance specificity. Based on the protein's structure:

  • The RNA-binding domains (Stm1 and HABP4_PAI-RBP1) are functionally important but may share homology with other RNA-binding proteins, potentially leading to cross-reactivity

  • Unique peptide sequences outside these conserved domains would make better antigens for specific antibody development

  • For phospho-specific antibodies, sites that show regulated phosphorylation during stress responses could be targeted

  • Using synthetic peptides corresponding to unique regions of AtRGGA is a viable alternative to full-length protein immunization

How can AT5G55150 antibodies be used to study RNA-protein interactions?

AT5G55150 antibodies can be powerful tools for investigating RNA-protein interactions through several approaches:

  • RNA immunoprecipitation (RIP):

    • Use the antibody to pull down AtRGGA and its associated RNAs

    • Coupled with sequencing (RIP-seq), this can identify the complete set of RNAs bound by AtRGGA in different conditions

    • Protocol should include crosslinking (formaldehyde or UV) to capture direct interactions

  • RNA electromobility shift assay (EMSA):

    • Similar to the approach used in the literature where recombinant His-RGGA was incubated with biotin-labeled RNA

    • Using the antibody in supershift assays can confirm the identity of the protein-RNA complex

    • Competition with unlabeled RNA can verify binding specificity

  • In situ detection of RNA-protein complexes:

    • Co-localization studies using fluorescent RNA probes and antibody detection

    • Particularly useful for examining spatiotemporal dynamics of interactions

For EMSA studies, data indicates that AtRGGA binds specifically to RNA in the poly(A-) fraction, suggesting targeted interactions with non-polyadenylated RNA species .

What methodological considerations are important when using AT5G55150 antibodies for immunoprecipitation?

When performing immunoprecipitation with AT5G55150 antibodies, several methodological factors should be considered:

  • Cell lysis conditions:

    • Use buffers that preserve protein-protein and protein-RNA interactions

    • Include RNase inhibitors if RNA-protein complexes are of interest

    • Consider the ionic strength of buffers as high salt can disrupt some interactions

  • Crosslinking options:

    • Formaldehyde (1%) for protein-protein interactions

    • UV crosslinking for direct RNA-protein interactions

    • DSP (dithiobis(succinimidyl propionate)) for reversible crosslinking

  • Controls:

    • IgG control antibodies from the same species

    • Preimmune serum for polyclonal antibodies

    • Immunoprecipitation from knockout plants as negative controls

    • Spiking experiments with recombinant protein to test efficiency

  • Elution strategies:

    • Peptide competition if epitope is known

    • SDS elution for maximum recovery

    • Native elution conditions if downstream functional assays are planned

What are the best experimental approaches to study AtRGGA function in stress response?

To investigate the role of AtRGGA in stress response mechanisms, researchers should consider a multi-faceted experimental approach:

  • Genetic approaches:

    • Analyze phenotypes of rgga knockout mutants under stress conditions

    • Compare with overexpression lines (e.g., 35S::FLAG-RGGA)

    • Data shows that germination under salt stress (120 mM NaCl) can reveal the role of AtRGGA in salt tolerance

  • Transcriptomics:

    • RNA-seq comparing wild-type and rgga mutants under control and stress conditions

    • Identify differentially expressed transcripts that may be regulated by AtRGGA

  • Protein interaction studies:

    • Immunoprecipitation followed by mass spectrometry to identify protein partners

    • Yeast two-hybrid screening to identify interactors

  • RBP-targeted approaches:

    • RIP-seq to identify bound RNAs

    • CLIP-seq for high-resolution mapping of binding sites

    • Functional analysis of identified target RNAs

  • Biochemical assays:

    • RNA-binding affinity measurements under different stress conditions

    • Post-translational modification analysis during stress exposure

How does AtRGGA post-translational modification affect its RNA-binding properties?

The relationship between post-translational modifications (PTMs) and RNA-binding activity represents an important area of research for AtRGGA:

  • Identification of PTMs:

    • Mass spectrometry analysis of AtRGGA under different stress conditions can reveal stress-induced modifications

    • Common PTMs to examine include phosphorylation, ubiquitination, and methylation

  • Effect on RNA binding:

    • EMSA assays comparing modified and unmodified proteins

    • Structure-function studies with mutated versions of AtRGGA that mimic or prevent specific modifications

  • Regulation during stress:

    • Time-course studies examining the correlation between PTM status and RNA-binding activity

    • Identification of kinases, phosphatases, or other enzymes that regulate AtRGGA function

This research direction is particularly valuable as many RNA-binding proteins show modified activity through phosphorylation or other PTMs during stress response pathways.

What computational approaches can aid in predicting AT5G55150 antibody epitopes and specificity?

Advanced computational methods can significantly enhance AT5G55150 antibody development:

  • Epitope prediction:

    • B-cell epitope prediction algorithms can identify regions likely to be immunogenic

    • Structure-based epitope mapping if 3D structural data is available

    • Conservation analysis to identify unique regions less likely to cross-react

  • De novo antibody design:

    • Computational tools like OptMAVEn-2.0 can design variable regions targeting specific epitopes

    • Rosetta-based affinity maturation can improve binding energies

    • Human string content (HSC) scoring can reduce potential immunogenicity

  • Cross-reactivity assessment:

    • Sequence alignment against proteome databases to identify potential cross-reactive proteins

    • Molecular docking simulations to evaluate binding energy differences between target and potential cross-reactive proteins

Research has shown that computational affinity maturation can improve binding energy by ~14 kcal/mol on average, potentially creating antibodies with significantly higher affinity and specificity .

How do different fixation and sample preparation methods affect AT5G55150 antibody performance in immunohistochemistry?

Sample preparation significantly impacts antibody performance in plant tissues:

  • Fixation methods comparison:

    • Aldehyde-based fixatives (paraformaldehyde, glutaraldehyde) preserve protein structure but may mask epitopes

    • Alcohol-based fixatives maintain antigenicity but may compromise tissue morphology

    • Cold acetone fixation often works well for plant tissues

  • Antigen retrieval techniques:

    • Heat-induced epitope retrieval in citrate buffer (pH 6.0)

    • Enzymatic retrieval using proteases like proteinase K

    • A combination approach may be optimal for complex plant tissues

  • Detection systems:

    • Fluorescent secondary antibodies for co-localization studies

    • Enzyme-based detection (HRP/AP) for permanent preparations

    • Amplification methods (tyramide signal amplification) for low-abundance targets

  • Controls for plant tissue immunohistochemistry:

    • Preabsorption controls with recombinant protein

    • Tissue from knockout plants

    • Comparison with promoter-GUS expression patterns

What are common pitfalls when working with AT5G55150 antibodies and how can they be addressed?

Researchers frequently encounter several challenges when working with plant protein antibodies like those for AT5G55150:

  • High background signal:

    • Increase blocking stringency (5% BSA or 5% milk)

    • Use plant-specific blocking agents that contain non-specific plant proteins

    • Increase wash duration and number of wash steps

    • Preabsorb antibody with plant extract from knockout plants

  • Poor signal detection:

    • Increase antibody concentration or incubation time

    • Try different extraction buffers to better solubilize AtRGGA

    • Use signal amplification methods

    • Consider enrichment procedures before detection

  • Inconsistent results between experiments:

    • Standardize plant growth conditions

    • Control for developmental stage and stress exposure

    • Use internal loading controls consistently

    • Prepare larger batches of antibody and aliquot to minimize freeze-thaw cycles

How can results from AT5G55150 antibody experiments be correlated with functional data?

  • Correlation with phenotypic data:

    • Compare protein expression/localization changes with phenotypes observed in knockout and overexpression lines

    • The germination analysis under salt stress can be correlated with AtRGGA protein levels

  • Integration with transcriptomic data:

    • Compare protein abundance changes with transcript level changes

    • Identify potential post-transcriptional regulation events where protein and transcript levels do not correlate

  • Structure-function correlations:

    • Use domain-specific antibodies to track different functional regions of AtRGGA

    • Correlate RNA-binding activity with protein levels in different conditions

  • Creating functional antibodies:

    • Develop antibodies that can inhibit RNA-binding function when added to in vitro assays

    • Use these to confirm functional importance of specific domains

What statistical approaches are appropriate for quantifying AT5G55150 antibody binding in different experimental contexts?

Proper statistical analysis is essential for interpreting antibody-based experimental data:

Experimental TechniqueAppropriate Statistical ApproachSample Size RecommendationCommon Pitfalls
Western BlotNormalized band intensity with ANOVA or t-testn ≥ 3 biological replicatesNot normalizing to loading controls; saturated signal
ImmunohistochemistryMean fluorescence intensity; colocalization coefficients5-10 fields of view from ≥3 samplesBackground subtraction inconsistencies
IP-Mass SpectrometryEnrichment ratios compared to IgG control; FDR correction3-4 biological replicatesNot controlling for non-specific binding
ELISAFour-parameter logistic regressionStandard curve with 7-8 points in duplicateEdge effects; improper plate blocking
ChIP-seq/RIP-seqPeak calling algorithms with FDR < 0.05≥2 biological replicatesInadequate input normalization

When quantifying western blots for AtRGGA, researchers should normalize band intensity to a stable reference protein (such as actin) and use Ponceau staining of Rubisco small subunit (RbcS) as a loading control, as demonstrated in published research .

How might new antibody engineering technologies improve AT5G55150 antibody development?

Emerging technologies in antibody engineering offer promising approaches for developing next-generation AT5G55150 antibodies:

  • Single-domain antibodies (nanobodies):

    • Smaller size allows better tissue penetration in plant samples

    • Greater stability under various experimental conditions

    • Potential for improved access to constrained epitopes

  • Recombinant antibody libraries:

    • Phage display libraries for rapid screening without animal immunization

    • Synthetic antibody libraries with optimized frameworks

    • Yeast display for fine affinity discrimination

  • Multispecific antibodies:

    • Dual targeting of AtRGGA and interacting proteins

    • Combining detection and functional modulation in one molecule

  • Computationally optimized antibodies:

    • De novo design using software like OptMAVEn-2.0

    • Rosetta-based affinity maturation

    • Structure-based epitope targeting

Recent research has demonstrated that computational approaches can successfully design antibody variable regions with improved binding energies, providing a powerful complement to traditional antibody development methods .

What are emerging applications of AT5G55150 antibodies in studying plant stress adaptation mechanisms?

Advanced applications of AT5G55150 antibodies are expanding our understanding of plant stress biology:

  • Single-cell proteomics:

    • Cell-type specific analysis of AtRGGA expression using antibody-based flow cytometry

    • Correlation with single-cell transcriptomics data

  • Proximity labeling approaches:

    • Antibody-enzyme fusion proteins (like APEX or BioID)

    • Mapping the spatial organization of AtRGGA-containing RNPs

  • Intrabody applications:

    • Expression of antibody fragments in plant cells to track or modulate AtRGGA function in vivo

    • Development of biosensors to detect conformational changes during stress

  • Antibody-guided CRISPR effectors:

    • Targeting modifiers of chromatin structure to AtRGGA genomic loci

    • Modulating AtRGGA expression with precision in specific cell types

These emerging technologies will provide unprecedented insights into the spatial and temporal dynamics of AtRGGA function during plant stress responses.

How do antibodies against AT5G55150 compare with antibodies against related plant RNA-binding proteins?

A comparative analysis of antibodies targeting different plant RNA-binding proteins reveals important considerations:

  • Specificity challenges:

    • RNA-binding proteins often share conserved domains

    • Higher specificity is achieved by targeting unique regions rather than RNA-binding domains

    • Knockout controls are essential for validating specificity

  • Cross-species reactivity:

    • Antibodies against conserved domains may work across plant species

    • Species-specific antibodies require targeting divergent regions

    • Testing predicted cross-reactivity with recombinant proteins from related species

  • Functional applications:

    • Some RBP antibodies can disrupt RNA binding in vitro

    • Others may be better suited for detection but not functional studies

    • Domain-specific antibodies can provide insights into protein organization

  • Technical performance comparison:

    • Antibodies against structured domains typically perform better in native applications

    • Antibodies against linear epitopes work better in denatured applications

    • Considering both types provides complementary information

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.